Health Infrastructure
Pharmaceutical Manufacturing Initiative
Juba, South Sudan
Project milestone / 2023Feasibility studies and legal documentation prepared.
The initiative
Project overview
A proposed pharmaceutical manufacturing facility in South Sudan, initiated with KSK Company Limited and Cairo-based JLK Company.
The initiative’s initial projected investment capital of US$50 million reflects its ambition to build local pharmaceutical manufacturing capacity.
The proposed site comprises 10,000 square metres of land in Juba owned by KSK Company Limited. By 2023, project preparation included legal documentation and technical and economic feasibility studies.
EABB’s role
Developing partnerships for local manufacturing.
EABB joined KSK Company Limited in cooperation with JLK Company to initiate the factory’s establishment.
The proposal connects EABB’s health infrastructure interests with industrial investment and regional development. Contact our team to discuss the initiative and opportunities for collaboration.
Explore the wider context
Part of a broader sector.
Explore EABB’s business scope and related activity in this sector.
About EABB Africa
Get started today
Let EABB be your partner in regional growth.
Start a conversation about your investment, trade or development ambitions across East Africa.